Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) will convene its 2025 Annual General Meeting (AGM) on 9 June 2026 at 10:00 a.m. in the Economic Development Zone, Chaoyang Town, Huinan County, Tonghua, Jilin Province, PRC.

Key ordinary resolutions include:

• Approval of the audited consolidated financial statements, Directors’ Report and independent auditor’s report for the year ended 31 December 2025.

• Approval of the Supervisory Committee Report for the same period.

• Re-appointment of Prism Hong Kong Limited as external auditor for the financial year ending 31 December 2026, with authority for the Board to fix remuneration.

• Endorsement of remuneration proposals for directors and supervisors for 2026.

• Re-election of the ninth-session Board, covering five directors—Mr. Zhang Yi, Mr. Xu Xiang Fu, Mr. Gao Qi Pin, Mr. Bai Jun Gui and Ms. Tian Jie—for a new three-year term ending at the 2029 AGM.

• Re-election of supervisors Mr. Yan Li Yu and Mr. Wang Ying Xu for the same three-year term.

Additional ordinary resolutions propose the election of three new executive directors—Mr. Wang Wei, Ms. Chi Chun Hong and Ms. Li Ning—and the appointment of Mr. Zhang Biao as a supervisor, each for a term running from 9 June 2026 to the 2029 AGM, with the Board authorised to determine individual remuneration.

A special resolution seeks shareholder approval for a general mandate allowing the Board to issue and deal with Domestic Shares and H Shares up to 20 percent of each class’s aggregate nominal value as at the date of approval.

Shareholders recorded on the register may appoint proxies to vote on their behalf. Proxy forms for H-shareholders must be lodged with Computershare Hong Kong Investor Services Limited, and those for Domestic shareholders with the company’s registered address, no later than 24 hours before the meeting or any adjournment.